Detalhe da pesquisa
1.
Overexpression of transmembrane protein 102 implicates poor prognosis and chemoresistance in epithelial ovarian carcinoma patients.
Am J Cancer Res
; 12(9): 4211-4226, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36225641